Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2005
08/10/2005EP1561116A2 Scd40l and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases
08/10/2005EP1560933A2 Methods and compositions for treating neurological disorders
08/10/2005EP1560925A2 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
08/10/2005EP1560920A2 Food flours with specific technological characteristics and low allergenicity
08/10/2005EP1560918A2 Compositions and methods for the modulation of viral maturation
08/10/2005EP1560917A1 Method of immobilising a protein to a zeolite
08/10/2005EP1560916A1 Expansion agents for stem cells
08/10/2005EP1560915A2 Assay methods for state-dependent calcium channel agonists/antagonists
08/10/2005EP1560851A1 Process for the purification of tnf-binding proteins using imac
08/10/2005EP1560850A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
08/10/2005EP1560849A1 Growth hormone variations in humans and its uses
08/10/2005EP1560848A2 Ptprk immunogenic peptide
08/10/2005EP1560847A2 Acetylated hmgb1 protein
08/10/2005EP1560846A2 Improving growth characteristics of filamentous microorganisms
08/10/2005EP1560845A1 Vaccine against hcv
08/10/2005EP1560844A1 Hepatitis c vaccine
08/10/2005EP1560843A2 Novel variants of rankl protein
08/10/2005EP1560842A2 Mta1s, a steroid hormone receptor corepressor
08/10/2005EP1560595A2 Fully human antibody fab fragments with human interferon-gamma neutralizing activity
08/10/2005EP1560594A1 Immunization of non-human mammals against streptococcus equi
08/10/2005EP1560593A1 Novel composition and methods for the treatment of immune related diseases
08/10/2005EP1560590A2 Synthetic complementary peptides and ophthalmologic uses thereof
08/10/2005EP1560491A2 Bacteriophage having modified holin and uses thereof
08/10/2005EP1483386A4 Novel nucleic acids and secreted polypeptides
08/10/2005EP1421096A4 CONSTITUTIVE PHOTOMORPHOGENESIS 1 (COP1) NUCLEIC ACID SEQUENCE FROM i ZEA MAYS /i AND ITS USE THEREOF
08/10/2005EP1409711A4 Compositions and methods for increasing amino acid absorption in mammals
08/10/2005EP1337643A4 Manipulation of plant life cycles and/or growth phases
08/10/2005EP1292697A4 Method for preparing a physiologically active il-18 polypeptide
08/10/2005EP1169441B8 Pharmaceutical compositions for the treatment of heart failure
08/10/2005EP1133559B1 Human orphan g protein-coupled receptor rup3
08/10/2005EP1123398B1 Molecular pathogenicide mediated plant disease resistance
08/10/2005EP1082427B1 Insulin-like growth factor binding protein-3 variants
08/10/2005EP1051487B1 Placental protein 13
08/10/2005EP0968288B1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a
08/10/2005EP0966685B1 Protein fragment complementation assays to detect biomolecular interactions
08/10/2005EP0931094B1 Methods for determining the presence of brain protein s-100 beta
08/10/2005EP0914344B8 ASSAY AND REAGENTS FOR QUANTIFYING hBNP
08/10/2005EP0914150B1 Recombinant neospora antigens and their uses
08/10/2005EP0909274B1 Method for purification of erythropoietin binding protein
08/10/2005EP0904295B1 Process for separating and analyzing hydrophobic proteins using thin layer chromatography
08/10/2005EP0894143B1 Vmp-like sequences of pathogenic borrelia
08/10/2005EP0837883B1 Method of solubilizing, purifying, and refolding protein
08/10/2005EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
08/10/2005EP0792357B1 Chemical modification of repetitive polymers to enhance water solubility
08/10/2005CN1653333A Identifying peptide modifications
08/10/2005CN1653193A 'doping' in walk-through mutagenesis
08/10/2005CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
08/10/2005CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
08/10/2005CN1653177A Muteins of placental growth factor type 1, preparation method and application thereof
08/10/2005CN1653176A Compositions and methods for generating an immune response
08/10/2005CN1653173A Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
08/10/2005CN1653088A Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
08/10/2005CN1653087A Collagen and method for producing same
08/10/2005CN1653086A Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis C virus
08/10/2005CN1653085A Fusion protein of HIV regulatory/accessory proteins
08/10/2005CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
08/10/2005CN1653080A Lymphatic and blood endothelial cell genes
08/10/2005CN1652820A Methods of treatment using CTLA-4 antibodies
08/10/2005CN1652819A Attenuation of metapneumovirus
08/10/2005CN1651577A Conditionally replicating viral vectors and their use
08/10/2005CN1651463A Mono methoxy polyethylene glycol-insulin complex substance and its preparation method
08/10/2005CN1651462A Method of monomerizing human serum albumin polymers
08/10/2005CN1651461A Polyethylene glycol modified and recombined human interleukin and its preparation method
08/10/2005CN1651460A Preparation process of high water and oil absorption soybean protein concentrate by using multi step modification technology
08/10/2005CN1651459A Small salt mustard sodium hydrogen pump protein gene TNHX1 and its anti salt application
08/10/2005CN1651458A Antigenic proteins of shrimp white spot syndrome virus and uses thereof
08/10/2005CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
08/10/2005CN1214244C Immuno assay solid-phase supporter, reagent kit, preparation and use thereof
08/10/2005CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
08/10/2005CN1214114C Activatable recombinant neurotoxins
08/10/2005CN1214113C Gene sequence of Japanese shistosome China mainland strain gynecophoric canal protein
08/10/2005CN1214112C Method of detecting sexual differentiation disruptor
08/10/2005CN1214110C Cassava vein mosaic virus promoters and uses thereof
08/10/2005CN1214041C Signal sequence trapping method
08/10/2005CN1213666C Soybean protein hydrolysates, their production and use
08/09/2005US6928368 Gene mining system and method
08/09/2005US6927322 Cabbage proteinase inhibitor gene confers resistance against plant pests
08/09/2005US6927321 Transformed soybean plant cell containing a nucleic acid molecule, a promoter heterologous with respect to the structural nucleic acid sequence
08/09/2005US6927320 A transgenic plant comprising a transgene, able expressing specifically in root progenitor tissues of embryos, coding herbicide, pathogen, or insect resist gene products, increase biosynthesis of starch, lignan or cellulose
08/09/2005US6927318 WIP, a WASP-associated protein
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927288 Plant thermogenic genes and proteins
08/09/2005US6927287 Nucleic acid encoding extracellular matrix protein or fragment thereof
08/09/2005US6927283 Modified acyl carrier proteins
08/09/2005US6927282 Clarification of protein precipitate suspensions using anionic polymeric flocculants
08/09/2005US6927281 isolated monoclonal antibody directed against an AAV type 2 capsid or protein, capable of detection in an ELISA assay, immunofluorescence or Western blotting
08/09/2005US6927280 Cocoa albumin and its use in the production of cocoa and chocolate flavor
08/09/2005US6927279 Prevention infections in cattle; vaccines; therapy for thrombosis
08/09/2005US6927207 polypeptides; cell recognition molecule which couples to the polypeptide, wherein the cell recognition molecule selectively binds to target cells; antitumor agents; used for example as a prophylactic against relapse after surgical tumour removal
08/09/2005US6927059 Compositions and methods for identifying agents which regulate autolytic processes in bacteria
08/09/2005US6927050 reacting organic pigments as substrates, with transglutaminase; photoelectricity; three dimensional recording
08/09/2005US6927046 Increased lysine production by gene amplification using coryneform bacteria
08/09/2005US6927044 IL-1 receptor based cytokine traps
08/09/2005US6927043 Cancer therapy
08/09/2005US6927042 Glycoprotein synthesis
08/09/2005US6927041 Human neuropeptide Y-like G protein-coupled receptor
08/09/2005US6927040 Polpeptide for use in the treatment of granulomatosis, nervous system and skin disorders, bacterial infections and leishmania
08/09/2005US6927031 Methods for identifying polypeptide factors interacting with RNA
08/09/2005US6927030 Methods of detecting and treating microsatellite-instability positive tumors using RIZ
08/09/2005US6927023 Detecting modulator of viral activity; for use in treatment of viral diseases
1 ... 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 ... 2916